Nalaganje...
In Vitro Metabolism of Oprozomib, an Oral Proteasome Inhibitor: Role of Epoxide Hydrolases and Cytochrome P450s
Oprozomib is an oral proteasome inhibitor currently under investigation in patients with hematologic malignancies or solid tumors. Oprozomib elicits potent pharmacological actions by forming a covalent bond with the active site N-terminal threonine of the 20S proteasome. Oprozomib has a short half-l...
Shranjeno v:
| izdano v: | Drug Metab Dispos |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
The American Society for Pharmacology and Experimental Therapeutics
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5452678/ https://ncbi.nlm.nih.gov/pubmed/28428366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/dmd.117.075226 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|